Grai Orthopedic Implants
The global orthopedic bone cement market is projected to grow at a CAGR of 5.8%, driven by an aging population and increasing sports-related injuries.
Antibiotic bone cement reduces the risk of post-operative infections by up to 40% compared to standard PMMA cement in high-risk patients.
Technological trends focus on "smart delivery," where antibiotics like Gentamicin and Vancomycin are released in controlled bursts.
Bulk procurement for high-volume arthroplasty centers focusing on cost-efficiency and clinical outcomes.
Agencies require reliable OEM/ODM partners with high production capacity and robust after-sales support.
Essential in "two-stage" revision surgeries for infected joints where high-dose antibiotic spacers are required.
Choosing a China Antibiotic Bone Cement Exporter provides a strategic advantage in terms of cost-to-quality ratio. Our facility is at the forefront of orthopedic manufacturing technology.
Factory covers an area of 15,000 m², certified with ISO13485, and BSCI. Our products are certified with CE, MDR, and FDA. With 500 employees, including 8 senior engineers and 10 QC, we provide minor customization, raw material traceability identification, and rigorous semi-product and finished product inspection.
We implement strict quality control processes and maintain advanced laboratory facilities for comprehensive testing. Our innovative solutions include over 300 different models available, with 10 new products introduced every month by our experienced R&D team.